Pfizer (PFE) reported Q2 FY 2020 earnings of $0.78 per share (versus $0.80 per share in Q2 FY 2019), beating analysts’ consensus estimate of $0.66 per share.
The company’s quarterly revenues amounted to $11.801 bln (-11.0% y/y), beating analysts’ consensus estimate of $11.553 bln.
The company also raised guidance for FY 2020, projecting EPS of $2.85-2.95 (compared to $2.82-2.92 previously and analysts’ consensus estimate of $2.72) and revenues of $48.6-50.6 bln (compared to $48.5-50.5 bln previously and analysts’ consensus estimate of $48.11 bln).
PFE rose to $38.86 (+3.52%) in pre-market trading.